Cargando…
Maximizing the return on taxpayers' investments in fundamental biomedical research
The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436771/ https://www.ncbi.nlm.nih.gov/pubmed/25926703 http://dx.doi.org/10.1091/mbc.E14-06-1163 |
_version_ | 1782372126943084544 |
---|---|
author | Lorsch, Jon R. |
author_facet | Lorsch, Jon R. |
author_sort | Lorsch, Jon R. |
collection | PubMed |
description | The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across the country. My job as director of NIGMS is to work to maximize the scientific returns on the taxpayers' investments. I describe how we are optimizing our investment strategies and funding mechanisms, and how, in the process, we hope to create a more efficient and sustainable biomedical research enterprise. |
format | Online Article Text |
id | pubmed-4436771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | The American Society for Cell Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-44367712015-07-16 Maximizing the return on taxpayers' investments in fundamental biomedical research Lorsch, Jon R. Mol Biol Cell Perspective The National Institute of General Medical Sciences (NIGMS) at the U.S. National Institutes of Health has an annual budget of more than $2.3 billion. The institute uses these funds to support fundamental biomedical research and training at universities, medical schools, and other institutions across the country. My job as director of NIGMS is to work to maximize the scientific returns on the taxpayers' investments. I describe how we are optimizing our investment strategies and funding mechanisms, and how, in the process, we hope to create a more efficient and sustainable biomedical research enterprise. The American Society for Cell Biology 2015-05-01 /pmc/articles/PMC4436771/ /pubmed/25926703 http://dx.doi.org/10.1091/mbc.E14-06-1163 Text en “ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society for Cell Biology. |
spellingShingle | Perspective Lorsch, Jon R. Maximizing the return on taxpayers' investments in fundamental biomedical research |
title | Maximizing the return on taxpayers' investments in fundamental biomedical research |
title_full | Maximizing the return on taxpayers' investments in fundamental biomedical research |
title_fullStr | Maximizing the return on taxpayers' investments in fundamental biomedical research |
title_full_unstemmed | Maximizing the return on taxpayers' investments in fundamental biomedical research |
title_short | Maximizing the return on taxpayers' investments in fundamental biomedical research |
title_sort | maximizing the return on taxpayers' investments in fundamental biomedical research |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436771/ https://www.ncbi.nlm.nih.gov/pubmed/25926703 http://dx.doi.org/10.1091/mbc.E14-06-1163 |
work_keys_str_mv | AT lorschjonr maximizingthereturnontaxpayersinvestmentsinfundamentalbiomedicalresearch |